A poorly structured medical device technical file is one of the fastest ways to trigger audit findings, Notified Body delays, or regulatory pushback, even when all the “right” documents technically exist.
Medical Device Technical File: Structure & Requirements Read More »
IVDR has fundamentally reshaped the regulatory landscape for in vitro diagnostic devices, and, yes, it’s still catching many manufacturers off guard years after its implementation.
IVD Consultancy: Practical IVDR Compliance Strategies Read More »
Even the most sophisticated medical device companies can stumble when their quality management system (QMS) fails. When that happens, it’s rarely a minor inconvenience – it is more often a chain reaction of recalls, warning letters, certificate suspensions, and huge remediation bills.
Top 5 Quality Management System Failures to Prevent Read More »
Post-Brexit, many medical device manufacturers are still navigating the split between CE marking and the UKCA mark — and the rules keep evolving. As the MHRA advances its “future regime” for medical devices, regulatory teams face the ongoing challenge of complying with both EU MDR obligations and the UK’s own UK MDR 2002 (as amended) framework.
CE Marking vs UKCA: 2026 Guide for Manufacturers Read More »
The newly revised ISO 10993-1:2025 has quietly done something big: it’s turned biological evaluation from a “tick-the-box biocompatibility test list” into a fully integrated risk narrative that regulators now expect to hold together scientifically, from chemistry through to clinical data.
ISO 10993-1:2025 – What’s New in Biological Evaluation Read More »
After years of “coming soon”, the EU has finally put a fixed date on reality: the first EUDAMED mandatory modules must be used from 28 May 2026.
EUDAMED Mandatory from May 2026: What You Need to Know Read More »
Since Brexit, appointing a UK Responsible Person (UKRP) has become a core requirement for most non-UK medical device manufacturers entering the Great Britain market. The role looks familiar (it resembles the EU Authorised Representative), but its obligations under the UK MDR 2002 (as amended) are distinct, legally binding, and far more visible to the MHRA.
UK Responsible Person (UKRP) Requirements & Compliance Guide Read More »
Building an ISO 13485-compliant medical device QMS is a demanding process at the best of times — but post-MDR and UK MDR amendments have made it even tougher for resource-constrained teams. Start-ups and SMEs now face the exact regulatory expectations as global manufacturers, while juggling limited bandwidth, rapid product iterations, and aggressive investor timelines.
ISO 13485 Consulting Services: How to Choose Your QMS Partner Read More »
Software is now the beating heart of modern medical devices. Whether you’re building a connected inhaler, an AI-driven diagnostic tool, or an embedded control system inside a Class III device, regulators expect one thing above all: evidence that your software is safe, controlled, validated, and maintained throughout its entire lifecycle.
IEC 62304 Explained: Medical Device Software Development Guide Read More »
Accurate medical device classification is the starting point for every UK regulatory journey — but post-Brexit, the rules are no longer identical to those of the EU. The UK MDR 2002 (as amended) remains the UK’s primary framework, and with further MHRA reforms planned for 2025, correct classification is more important than ever.
Medical Device Classification UK: Complete MHRA Guide 2025 Read More »
For help with the checklist or other aspects of your compliance journey, please reach out to us at Patient Guard and our experts would be happy to help.
UK Office
Thank you! The checklist is now ready to download.
For help with the checklist or other aspects of your compliance journey, please reach out to us at Patient Guard and our experts would be happy to help.
UK Office